3.365
Finanzdaten der Recursion Pharmaceuticals Inc-Aktie (RXRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
586.72%
35.54
|
5.175 | 19.22 | 14.74 | 4.546 |
| Cost Of Revenue |
2.81%
14.28
|
14.69 | 20.16 | 21.83 | 12.79 |
| Gross Profit |
323.54%
21.26
|
-9.512 | -0.938 | -7.084 | -8.248 |
|
|
20.34%
129.60
|
162.69 | 175.29 | 184.28 | 175.52 |
| Benefits Costs and Expenses |
14.21%
143.64
|
167.43 | 191.12 | 217.39 | 183.44 |
| Costs And Expenses |
18.89%
143.87
|
177.38 | 195.45 | 206.11 | 188.31 |
| Operating Income/Loss |
37.09%
-108.33
|
-172.20 | -176.23 | -191.37 | -183.77 |
| Nonoperating Income/Loss |
97.67%
0.232
|
9.952 | 4.33 | -11.28 | 4.869 |
| Income/Loss From Continuing Operations Before Tax |
33.37%
-108.10
|
-162.25 | -171.90 | -202.65 | -178.90 |
| Income Tax Expense/Benefit |
566.67%
0.02
|
0.003 | - | -0.158 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
33.36%
-108.12
|
-162.25 | -171.90 | -202.49 | -178.91 |
|
|
33.36%
-108.12
|
-162.25 | -171.90 | -202.49 | -178.91 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.45%
24.80
|
446.99 | 417.36 | 402.77 | 20.76 |
| Diluted Average Shares |
94.45%
24.80
|
446.99 | 417.36 | 402.77 | 20.76 |
| Basic Earnings Per Share |
52.78%
-0.17
|
-0.36 | -0.41 | -0.50 | -0.57 |
| Diluted Earnings Per Share |
52.78%
-0.17
|
-0.36 | -0.41 | -0.50 | -0.57 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):